Answer
Canakinumab (Ilaris) must not be re-administered if signs and symptoms of DRESS are present and no alternative cause can be established, and a different treatment should be considered.
Sources for this answer
- Ilaris 150mg/ml Solution for InjectionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked